Monday, December 23, 2024
HomeTagsDouglas Thomson

Douglas Thomson

Pneumagen Announces First Patient Dosed in Phase 2 Proof of Concept

Pneumagen, a clinical stage biotech company developing Neumifil, an intranasal, broad-spectrum antiviral treatment to prevent or, if infected reduce and manage viral respiratory tract...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics